YKYoung Chul Kye

Young Chul Kye

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Young Chul Kye has a total of 32 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Low‐fluence Q‐switched Nd:YAG laser for the treatment of melasma in Asian patients

    by Jae Eun Choi, Dong Won Lee, Soo Hong Seo, Hyo Hyun Ahn, Young Chul Kye

    Summary: Background: Melasma is a common acquired facial pigmentary disorder that is resistant to various modalities of treatment. Recently, the low‐fluence 1064‐nm Q‐switched neodymium‐doped yttrium aluminum garnet laser (QSNY) has emerged as the new gold standard of melasma treatment in Asia.Objective: To evaluate the efficacy and safety of low‐fluence 1064‐nm QSNY in Asian patients with melasma.Methods: Data of patients with melasma treated with low‐fluence QSNY in the department of dermatology at the Korea University Anam Hospital were reviewed retrospectively. A 1064‐nm QSNY with 8 mm spot size and fluence of 1.2‐2.0 J/cm2 at 10 Hz was used. The results were evaluated using the modified Melasma Area and Severity Index (mMASI) score and the physician's global assessment (PGA).Results: A total of 40 Korean patients with Fitzpatrick skin type III to IV were included. Patients were treated for a median of 10 sessions at a median of 1‐week intervals. The mean mMASI score decreased by 54.23% from a baseline of 3.19 ± 2.64 to 1.46 ± 1.06 after treatment. On PGA, 1 out of 40 patients (2.5%) showed excellent improvement, 14 (35%) good, 15 (37.5%) fair, 6 (15%) poor, and 4 (10%) no improvement. However, two patients showed mottled hypopigmentation and rebound hyperpigmentation.Conclusion: Low‐fluence 1064‐nm QSNY appears to be a safe and effective treatment for Asian patients with melasma.


  • Retreatment using a dual mode of low-fluence Q-switched and long-pulse Nd:YAG laser in patients with melasma aggravation after previous therapy

    by Chun Pil Choi, Seon Mi Yim, Soo Hong Seo, Hyo Hyun Ahn, Young Chul Kye, Jae Eun Choi

    Background: Aggravated melasma after treatment is vulnerable to stimulation, can easily deteriorate, and may be distressing without proper management. Objective: To retrospectively assess the effectiveness and safety of combination therapy using low-fluence Q-switched neodymium-doped yttrium aluminum garnet (Nd:YAG) laser (QSNY) and long-pulse Nd:YAG laser (LPNY) (dual toning) in patients with rebound melasma. Materials and methods: A total of 30 patients with aggravated melasma after previous therapy who were treated with dual toning were enrolled. A total of 10 sessions were conducted at 1-week intervals, followed by maintenance treatment. The results were evaluated using the modified Melasma Area and Severity Index (mMASI) and the physician's global assessment (PGA) before and 2 months after completing the 10 treatment sessions. Results: The baseline mMASI was 10.48 ± 3.64, which significantly decreased to 3.22 ± 1.45 2 months after completing the 10 treatment sessions (p < 0.001). Twenty-four patients (80%) had PGA grade 4 (76–100% improvement) and 6 patients (20%) had PGA grade 3 (51–75% improvement). Conclusion: Dual toning may be a safe and effective salvage treatment for patients with aggravated melasma after previous treatment. LPNY may stabilize melasma activity to prevent rebound hyperpigmentation via dermal remodeling.


  • Ablative fractional laser treatment for hypertrophic scars: comparison between Er:YAG and CO2 fractional lasers

    by Jae Eun Choi, Ga Na Oh, Jong Yeob Kim, Soo Hong Seo, Hyo Hyun Ahn, Young Chul Kye

    Background: Nonablative fractional photothermolysis has been reported to show early promise in the treatment of hypertrophic scars, but there are few reports on ablative fractional photothermolysis for the treatment of hypertrophic scars. Aim: To evaluate and compare the efficacy and safety of Er:YAG fractional laser (EYFL) and CO2 fractional laser (CO2FL) for treatment of hypertrophic scars. Methods: Thirteen patients with hypertrophic scars were treated with 2,940 nm EYFL, and ten were treated with 10,600 nm CO2FL. An independent physician evaluator assessed the treatment outcomes using Vancouver scar scale (VSS) and 5-point grading scale (grade 0, no improvement; grade 1, 1–25%; grade 2, 26–50%; grade 3, 51–75%; grade 4, 76–100% improvement). Patients are queried about their subjective satisfaction with the treatment outcomes. Results: After the final treatment, average percentage changes of VSS were 28.2% for EYFL and 49.8% for CO2FL. Improvement was evident in terms of pliability, while insignificant in terms of vascularity and pigmentation. Based on physician's global assessment, mean grade of 1.8 for EYFL and 2.7 for CO2FL was achieved. Patient's subjective satisfaction scores paralleled the physician's objective evaluation.Conclusion: CO2FL is a potentially effective and safe modality for the treatment of hypertrophic scars, particularly in terms of pliability.


  • A firm, bluish, hemorrhagic nodule on the left heel

    by Hee Joo Kim, Jong Yeob Kim, Jae Eun Choi, Young Chul Kye, Hyo Hyun Ahn, Soo Hong Seo


  • Better understanding of digital photography for skin color measurement: With a special emphasis on light characteristics

    by Soo Hong Seo, Jae Hwan Kim, Ji Woong Kim, Young Chul Kye, Hyo Hyun Ahn

    Digital photography can be used to measure skin color colorimetrically when combined with proper techniques. To better understand the settings of digital photography for the evaluation and measurement of skin colors, we used a tungsten lamp with filters and the custom white balance (WB) function of a digital camera. All colored squares on a color chart were photographed with each original and filtered light, analyzed into CIELAB coordinates to produce the calibration method for each given light setting, and compared statistically with reference coordinates obtained using a reflectance spectrophotometer. They were summarized as to the typical color groups, such as skin colors. We compared these results according to the fixed vs. custom WB of a digital camera. The accuracy of color measurement was improved when using light with a proper color temperature conversion filter. The skin colors from color charts could be measured more accurately using a fixed WB. In vivo measurement of skin color was easy and possible with our method and settings. The color temperature conversion filter that produced daylight-like light from the tungsten lamp was the best choice when combined with fixed WB for the measurement of colors and acceptable photographs.


  • Treatment of Becker's Nevi With a Long-Pulse Alexandrite Laser

    by Jae Eun Choi, Ji Woong Kim, Soo Hong Seo, Sang Wook Son, Hyo Hyun Ahn, Young Chul Kye

    Becker's nevus (BN) can be a distressing cosmetic handicap for patients and a treatment challenge for physicians. Various treatment modalities have been used, but repigmentation commonly occurs after treatment. To evaluate the efficacy of long-pulse alexandrite laser in the treatment of BN. Eleven Korean patients with Fitzpatrick skin type III to V were included in this study. A long-pulsed alexandrite laser with a wavelength of 755 nm and a pulse duration of 3 ms was used. Patients were treated with a fluence of 20 to 25 J/cm(2) and a spot size of 15 to 18 mm. Cryogen spray cooling was not used. Two patients had excellent responses, five had good responses, and four had fair responses. Hair density simultaneously decreased with treatment in all patients. Although mild hypopigmentation was observed in some patients, and partial hypertrophic scarring was observed in one patient, the outcomes were cosmetically acceptable. No repigmentation was noted during the follow-up period. A long-pulsed alexandrite laser without cryogen spray cooling is an effective and safe alternative in the treatment of BN.


  • Treatment of Vascular Skin Lesions with the Variable Pulse 595 nm Pulsed Dye Laser

    by Sang-Hyuk Woo, Hyo-Hyun Ahn, Soo-Nam Kim, Young-Chul Kye

    In the dermatology field, variable-pulse 595 nm pulsed dye lasers (PDLs) are now being widely used to treat vascular skin lesions. However, there is little information available on variable-pulse 595 nm PDL treatment of dark-skinned patients. The objective of this study was to evaluate the outcome of variable-pulse 595 nm PDL treatment on Korean patients. Two hundred thirty-nine patients (Fitzpatrick skin phototypes III to V) with vascular skin lesions, such as nevus flammeus, telangiectasia, or hemangioma, were included in this study. All patients were treated with a variable-pulse 595 nm PDL, and the outcomes were assessed by comparing preoperative and postoperative photographs. The average number of treatments per patient was 4.29, and 51.9% of patients showed a good (51-75% clearance) to excellent (76-100% clearance) response. For nevus flammeus, 48.0% of the patients achieved good to excellent results. The gender and age of the patients did not influence the clinical response; however, lesions of the head and neck were found to respond more favorably to treatment. For telangiectasia, 78.0% of patients showed good to excellent results, and, again, the gender and age of the patients did not alter the treatment outcome. For hemangioma, the male to female ratio of patients was 1.0:3.1 and 54.1% of the patients achieved a good to excellent response. Superficial hemangioma showed a better clinical response than deep hemangioma, and the lesions of younger patients responded more favorably than those of older patients. The variable-pulse 595 nm PDL was found to be effective for treating several vascular skin lesions in dark-skinned patients. However, there were differences in treatment outcome owing to disease, age, and the location of the lesions.


  • Open Access

    Targeted Broadband UVB Phototherapy forthe Treatment of Localized Vitiligo

    by Jeong Eun Kim, Hyo Hyun Ahn, Young Chul Kye

    Kim JE, et al. Ann Dermatol. 2008 Sep;20(3):107-112. http://dx.doi.org/10.5021/ad.2008.20.3.107


  • Dysregulated Inflammatory Cytokine Response in Lipopolysaccharide- and Peptidoglycan-Stimulated Monouclear Cells of a Patient with Blau Syndrome

    by Sang Wook Son, Jin Lee, Jae Eun Choi, Il Hwan Kim, Jeongwon Sohn, Young Chul Kye, Kwang Chul Lee, JungHwa Lee